Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
Clinical trial NCT02374242 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02374242
- Sponsor
- Melanoma Institute Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-04
- Primary completion
- 2017-09-04
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.